迈克生物：公司目前暂未涉及AI健康应用App的开发

Core Viewpoint - The company, Mike Biotech (300463.SZ), has stated that it is currently not involved in the development of AI health application apps [1]. Group 1 - An investor inquired on the investor interaction platform about the company's expertise in the medical diagnostics field, particularly in the in vitro diagnostic value traceability system, suggesting that the company should be more professional and authoritative than Ant Group [3]. - The investor expressed hope that the company would leverage its advantages in the entire in vitro diagnostic industry chain to develop an AI health app quickly, in order to capture market share and expand its user base [3].